Literature DB >> 23266920

Obtaining consent from both parents for pediatric research: what does "reasonably available" mean?

Daniel K Nelson1, Debra Skinner, Sonia Guarda, Summer Choudhury, John Sideris, Leah Barnum, Kristy Ten Haagen, Quetrell Heyward, Donald B Bailey.   

Abstract

OBJECTIVE: Circumstances surrounding parental availability and decision-making were examined in the setting of a research protocol involving newborn screening (NBS) for fragile X syndrome, in which the institutional review board (IRB) had determined that consent (permission) was required from both parents.
METHODS: A survey was conducted with 3001 families who were approached to participate in optional NBS. In addition to basic demographics, observational notes detailed the reasons why fathers were not present or deemed "not reasonably available" (per IRB regulations), and content analysis identified the factors for this lack of availability. Logistic regression models estimated the likelihood that both parents would agree to enroll their infant in the screening project.
RESULTS: Fathers were not present in 589 cases, including 158 in which fathers were ultimately determined to be not reasonably available. Primary reasons for father's unavailability were deployment with the military, incarceration, living out of state, or not involved in the mother's life. In cases in which both parents were available, 64% agreed to enroll in the NBS study. Criteria to guide researchers in making required determinations were developed from consultations with IRB officials and legal counsel.
CONCLUSIONS: In a large-scale population-based study, 19.6% of fathers were absent for the consent process. Scenarios encountered underscore the complexity of parental relations and their implications for obtaining consent for research involving children. The algorithm developed may serve as a useful tool for others in applying the regulatory requirements for dual parental permission.

Entities:  

Mesh:

Year:  2012        PMID: 23266920      PMCID: PMC3529951          DOI: 10.1542/peds.2012-1278

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Changing perspectives on the benefits of newborn screening.

Authors:  Donald B Bailey; Laura M Beskow; Arlene M Davis; Debra Skinner
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

2.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

3.  Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project.

Authors:  Debra Skinner; Summer Choudhury; John Sideris; Sonia Guarda; Allen Buansi; Myra Roche; Cynthia Powell; Donald B Bailey
Journal:  Pediatrics       Date:  2011-05-29       Impact factor: 7.124

4.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

5.  Screening for Fragile X Syndrome: parent attitudes and perspectives.

Authors:  Debra Skinner; Karen L Sparkman; Donald B Bailey
Journal:  Genet Med       Date:  2003 Sep-Oct       Impact factor: 8.822

Review 6.  Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.

Authors:  Donald B Bailey; Debra Skinner; Arlene M Davis; Ian Whitmarsh; Cynthia Powell
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

7.  Guardian availability in children evaluated in the emergency department for blunt head trauma.

Authors:  James F Holmes; Richard Holubkov; Nathan Kuppermann
Journal:  Acad Emerg Med       Date:  2008-11-12       Impact factor: 3.451

8.  Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Authors:  Ned Calonge; Nancy S Green; Piero Rinaldo; Michele Lloyd-Puryear; Denise Dougherty; Coleen Boyle; Michael Watson; Tracy Trotter; Sharon F Terry; R Rodney Howell
Journal:  Genet Med       Date:  2010-03       Impact factor: 8.822

Review 9.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

  9 in total
  8 in total

1.  Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid.

Authors:  Megan A Lewis; Ryan S Paquin; Myra I Roche; Robert D Furberg; Christine Rini; Jonathan S Berg; Cynthia M Powell; Donald B Bailey
Journal:  Pediatrics       Date:  2016-01       Impact factor: 7.124

2.  Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening.

Authors:  Donald B Bailey; Anne Wheeler; Elizabeth Berry-Kravis; Randi Hagerman; Flora Tassone; Cynthia M Powell; Myra Roche; Louise W Gane; John Sideris
Journal:  Pediatrics       Date:  2015-07-13       Impact factor: 7.124

3.  The perils of protection: vulnerability and women in clinical research.

Authors:  Toby Schonfeld
Journal:  Theor Med Bioeth       Date:  2013-06

4.  Women's Views About a Paternal Consent Requirement for Biomedical Research in Pregnancy.

Authors:  Kristen A Sullivan; Maggie Little; Nora E Rosenberg; Tiwonge Mtande; Chifundo Zimba; Elana Jaffe; Jean Anderson; Jenell S Coleman; Sappho Gilbert; Marielle S Gross Wolf; Irving Hoffman; Lisa Rahangdale; Ruth Faden; Anne Drapkin Lyerly
Journal:  J Empir Res Hum Res Ethics       Date:  2018-07-12       Impact factor: 1.742

5.  A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants.

Authors:  Khalid AlFaleh; Eman Alluwaimi; Ahlam AlOsaimi; Sheikha Alrajebah; Bashayer AlOtaibi; Fatima AlRasheed; Turki AlKharfi; Bosco Paes
Journal:  BMC Pediatr       Date:  2015-04-22       Impact factor: 2.125

6.  A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants: A Randomized Clinical Trial.

Authors:  Andreas Repa; Christoph Binder; Margarita Thanhaeuser; Alexandra Kreissl; Eleonore Pablik; Mercedes Huber-Dangl; Angelika Berger; Nadja Haiden
Journal:  J Pediatr       Date:  2017-12-18       Impact factor: 4.406

7.  Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.

Authors:  Laura V Milko; Christine Rini; Megan A Lewis; Rita M Butterfield; Feng-Chang Lin; Ryan S Paquin; Bradford C Powell; Myra I Roche; Katherine J Souris; Donald B Bailey; Jonathan S Berg; Cynthia M Powell
Journal:  Trials       Date:  2018-06-28       Impact factor: 2.279

8.  Automated screening for Fragile X premutation carriers based on linguistic and cognitive computational phenotypes.

Authors:  Arezoo Movaghar; Marsha Mailick; Audra Sterling; Jan Greenberg; Krishanu Saha
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.